- Report
- August 2021
- 10 Pages
Global
From €3027EUR$3,150USD£2,588GBP
- Report
- September 2020
- 10 Pages
Global
From €2883EUR$3,000USD£2,464GBP
The Percutaneous Pulmonary Valve (PPV) is a medical device used in the treatment of pulmonary valve stenosis, a condition in which the pulmonary valve does not open properly. It is a minimally invasive procedure that involves the insertion of a catheter into the pulmonary artery, allowing the replacement of the stenotic valve with a new valve. The PPV is a relatively new technology, and is becoming increasingly popular due to its minimally invasive nature and the potential for improved outcomes.
The PPV market is a rapidly growing segment of the pulmonary medicine industry, with a wide range of products available. Companies such as Edwards Lifesciences, Medtronic, Boston Scientific, and St. Jude Medical are leading the way in the development of PPV technology. Other companies such as Abbott, Sorin Group, and Neovasc are also active in the PPV market. Show Less Read more